View ICR - OIRA Conclusion



0910-0693 201706-0910-016
Historical Active 201503-0910-011
HHS/FDA CDER
Guidance for Industry on User Fee Waivers, Reductions, and Refunds for Drug and Biological Products
Extension without change of a currently approved collection   No
Regular
Approved without change 10/25/2017
08/17/2017
  Inventory as of this Action Requested Previously Approved
10/31/2020 36 Months From Approved 10/31/2017
183 0 124
2,630 0 2,004
0 0 0